(19)
(11) EP 1 506 002 A2

(12)

(88) Date of publication A3:
09.12.2004

(43) Date of publication:
16.02.2005 Bulletin 2005/07

(21) Application number: 03753102.7

(22) Date of filing: 16.05.2003
(51) International Patent Classification (IPC)7A61K 38/21, A61K 39/395, C07K 16/00
(86) International application number:
PCT/US2003/015874
(87) International publication number:
WO 2003/097082 (27.11.2003 Gazette 2003/48)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 17.05.2002 US 150742
22.05.2002 US 383310 P

(71) Applicant: Protein Design Labs
Fremont, CA 94555 (US)

(72) Inventors:
  • EHRHARDT, Rolf
    San Francisco, CA 94131 (US)
  • LEVITT, DAN
    San Francisco, CA 94118 (US)
  • LAYUG, Beth
    San Francisco, CA 94122 (US)
  • O'NEILL, Don
    Furlong, PA 18925 (US)
  • WEDEL, Nancy
    Oakland, CA 94610 (US)
  • OSTBERG, Lars
    Los Altos, CA 94022 (US)

(74) Representative: Schüssler, Andrea, Dr. 
Kanzlei Huber & SchüsslerTruderinger Strasse 246
81825 München
81825 München (DE)

   


(54) TREATMENT OF CROHN'S DISEASE OR PSORIASIS USING ANTI-INTEFERON GAMMA ANTIBODIES